Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Pathology of Allograft Liver Dysfunction

  • Chapter
  • First Online:
Pediatric Hepatology and Liver Transplantation

  • 1693 Accesses

Abstract

In spite of significant improvements, availability, and deeper knowledge of many tools of investigation in liver transplanted patients (US, angiography, cholangiography, CT, and MRI), liver biopsy maintains a central role in the diagnosis and management of early and late postsurgery complications. Information arising from liver biopsy interpretation may be crucial for clinical decisions and therapy arrangements, but, to reach this goal, tissue samples must be representative, processed properly, and carefully evaluated by committed pathologists in order to discover significant histological pictures. Continuous and detailed communications between hepatologists and pathologists are necessary to obtain correct diagnostic details from this unique powerful procedure. Biochemical liver tests are associated with poor sensitivity and specificity in the diagnosis of graft dysfunction and usually provide only limited information about the target and the severity of graft damage. Moreover protocol scheduled liver biopsies are able to detect the early and asymptomatic stages of many diseases, occurring late after transplant and in some cases allow an early treatment that may avoid or delay graft injury and graft loss. Detailed and updated knowledge of the histological alterations observed in liver samples may improve the understanding of the post-transplant diseases that could improve post-transplant care and the final outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bubak ME, Porayko MK, Krom RA, Wiesner RH. Complications of liver biopsy in liver transplant patients: increased sepsis associated with choledochojejunostomy. Hepatology. 1991;14:1063.

    Article  CAS  Google Scholar 

  2. Larson AM, Chan GC, Wartelle CF, et al. Infection complicating percutaneous liver biopsy in liver transplant recipients. Hepatology. 1997;26:1406.

    Article  CAS  Google Scholar 

  3. Anomynous. Comprehensive update of the Banff Working Group on Liver Allograft Pathology: introduction of antibody-mediated rejection. Am J Transplant. 2016;16(10):2816–35. https://doi.org/10.1111/ajt.13909. Epub 2016 Jul 14.

    Article  Google Scholar 

  4. Abraham SC, Furth EE. Receiver operating characteristic analysis of serum chemical parameters as tests of liver transplant rejection and correlation with histology. Transplantation. 1995;59:740.

    Article  CAS  Google Scholar 

  5. Anonymous. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology. 1997;25(3):658–63.

    Article  Google Scholar 

  6. McVicar JP, Kowdley KV, Bacchi CE, et al. The natural history of untreated focal allograft rejection in liver transplant recipients. Liver Transpl Surg. 1996;2:154.

    Article  CAS  Google Scholar 

  7. Bartlett AS, Ramadas R, Furness S, et al. The natural history of acute histologic rejection without biochemical graft dysfunction in orthotopic liver transplantation: a systematic review. Liver Transpl. 2002;8:1147.

    Article  Google Scholar 

  8. Thurairajah PH, Carbone M, Bridgestock H, et al. Late acute liver allograft rejection; a study of its natural history and graft survival in the current era. Transplantation. 2013;95:955.

    Article  Google Scholar 

  9. Kim C, Aono S, Marubashi S, et al. Significance of alanine aminopeptidase N (APN) in bile in the diagnosis of acute cellular rejection after liver transplantation. J Surg Res. 2012;175:138.

    Article  CAS  Google Scholar 

  10. Asaoka T, Kato T, Marubashi S, et al. Differential transcriptome patterns for acute cellular rejection in recipients with recurrent hepatitis C after liver transplantation. Liver Transpl. 2009;15:1738.

    Article  Google Scholar 

  11. Massoud O, Heimbach J, Viker K, et al. Noninvasive diagnosis of acute cellular rejection in liver transplant recipients: a proteomic signature validated by enzyme-linked immunosorbent assay. Liver Transpl. 2011;17:723.

    Article  Google Scholar 

  12. Shaked A, Chang BL, Barnes MR, et al. An ectopically expressed serum miRNA signature is prognostic, diagnostic, and biologically related to liver allograft rejection. Hepatology. 2017;65:269.

    Article  CAS  Google Scholar 

  13. Goldstein NS, Hart J, Lewin KJ. Diffuse hepatocyte ballooning in liver biopsies from orthotopic liver transplant patients. Histopathology. 1991;18:331.

    Article  CAS  Google Scholar 

  14. Kerkar N, Hadzic N, Davies ET, Portmann B, Donaldson PT, Rela M, Heaton ND, Vergani D, Mieli-Vergani G. De-novo autoimmune hepatitis after liver transplantation. Lancet. 1998;351(9100):409–13.

    Article  CAS  Google Scholar 

  15. Fiel MI, Schiano TD. Plasma cell hepatitis (de-novo autoimmune hepatitis) developing post liver transplantation. Curr Opin Organ Transplant. 2012;17(3):287–92.

    Article  Google Scholar 

  16. Avitzur B, Ngan M, Lao A, Fecteau VL. Prospective evaluation of the prevalence and clinical significance of positive autoantibodies after pediatric liver transplantation. J Pediatr Gastroenterol Nutr. 2007;45:222–7.

    Article  CAS  Google Scholar 

  17. Duclos-Vallee JC, Johanet C, Bach JF, Yamamoto AM. Autoantibodies associated with acute rejection after liver transplantation for type-2 autoimmune hepatitis. J Hepatol. 2000;33:163–6.

    Article  CAS  Google Scholar 

  18. D’Antiga L, Dhawan A, Portmann B, Francavilla R, Rela M, Heaton N, et al. Late cellular rejection in paediatric liver transplantation: aetiology and outcome. Transplantation. 2002;73:80–4.

    Article  Google Scholar 

  19. Miyagawa-Hayashino HH, Egawa H, Hayashino Y, Sakurai T, Minamiguchi S, et al. Outcome and risk factors of de novo autoimmune hepatitis in living-donor liver transplantation Transplantation, vol. 78; 2004. p. 128–35.

    Google Scholar 

  20. Hubscer SG. Pathology of liver transplantation. Semin Liver Dis. 2009;29:74–90.

    Article  Google Scholar 

  21. Ekong UD, McKiernan P, Martinez M, et al. Long-term outcomes of de novo autoimmune hepatitis in pediatric liver transplant recipients. Pediatr Transplant. 2017;21:e12945.

    Article  Google Scholar 

  22. Porter KA. Pathology of liver transplantation. Transplant Rev. 1969;2:129–70.

    CAS  PubMed  Google Scholar 

  23. Cuenca AG, Kim HB, Vakili K. Pediatric liver transplantation. Semin Pediatr Surg. 2017;26(4):217–23. https://doi.org/10.1053/j.sempedsurg.2017.07.014. Epub 2017 Jul 26.

    Article  PubMed  Google Scholar 

  24. Anonymous. Liver biopsy interpretation for causes of late liver allograft dysfunction. Hepatology. 2006;44:489–501. https://doi.org/10.1002/hep.21280.

    Article  Google Scholar 

  25. Hubscher SG. Antibody-mediated rejection in the liver allograft. Curr Opin Organ Transplant. 2012;17:280–286.74.

    CAS  PubMed  Google Scholar 

  26. Nakamura K, Murase N, Becich MJ, et al. Liver allograft rejection in sensitized recipients. Observations in a clinically relevant small animal model. Am J Pathol. 1993;142:1383–91.

    CAS  PubMed  PubMed Central  Google Scholar 

  27. Page C, Rose M, Yacoub M, Pigott R. Antigenic heterogeneity of vascular endothelium. Am J Pathol. 1992;141:673–83.

    CAS  PubMed  PubMed Central  Google Scholar 

  28. Astarcioglu I, Cursio R, Reynes M, Gugenheim J. Increased risk of antibody-mediated rejection of reduced-size liver allografts. J Surg Res. 1999;87:258–62.

    Article  CAS  Google Scholar 

  29. Liu X, Xu J, Brenner DA, Kisseleva T. Reversibility of liver fibrosis and inactivation of fibrogenic myofibroblasts. Curr Pathobiol Rep. 2013;1:209–14.

    Article  Google Scholar 

  30. Haga H, Egawa H, Fujimoto Y, et al. Acute humoral rejection and C4d immunostaining in ABO-blood type-incompatible liver transplantation. Liver Transpl. 2006;12:457–64.

    Article  Google Scholar 

  31. Sharma S, Gurakar A, Jabbour N. Biliary strictures following liver transplantation: past, present and preventive strategies. Liver Transpl. 2008;14:759–69.

    Article  Google Scholar 

  32. Neil DAH, Hubscher SG. Are parenchymal changes in early post-transplant biopsies related to preservation-reperfusion injury or rejection? Transplantation. 2001;71:1566–1572.5.

    Article  CAS  Google Scholar 

  33. Romero FA, Razonable RR. Infections in liver transplant recipients. World J Hepatol. 2011;3:83–92.

    Article  Google Scholar 

  34. Sun HY, Cacciarelli TV, Singh N. Identifying a targeted population at high risk for infections after liver transplantation in the MELD era. Clin Transpl. 2011;25:420–5.

    Article  Google Scholar 

  35. van Hoek B, de Rooij BJ, Verspaget HW. Risk factors for infection after liver transplantation. Best Pract Res Clin Gastroenterol. 2012;26:61–72.

    Article  Google Scholar 

  36. Fishman JA, Iss a NC. Infection in organ transplantation: risk factors and evolving patterns of infection. Infect Dis Clin N Am. 2010;24:273–83.

    Article  Google Scholar 

  37. Balmer ML, Slack E, de Gottardi A, Laws on MA, Hapfelmeier S, Miele L, Grieco A, Van Vlierberghe H, Fahrner R, Patut o N, Bernsmeier C, Ronchi F, Wyss M, Stroka D, Dickgreber N, Heim MH, McCoy KD, Macpherson AJ. The liver may act as a firewall mediating mutualism between the host and its gut commensal microbiota. Sci Transl Med. 2014;6:237ra66.

    Article  Google Scholar 

  38. Fagiuoli S, Colli A, Bruno R, Craxi A, Gaeta GB, Grossi P, Mondelli MU, Puoti M, Sagnelli E, Stefani S, Toniutto P, Burra P, Group AST. Management of infections pre- and post-liver transplantation: report of an AISF consensus conference. J Hepatol. 2014;60:1075–89.

    Article  Google Scholar 

  39. Waldman WJ, Knight DA, Adams PW, Orosz CG, Sedmak DD. In vitro induction of endothelial HLA class II antigen expression by cytomegalovirus-activated CD4+ T cells. Transplantation. 1993;56:1504–12.

    Article  CAS  Google Scholar 

  40. Arnold JC, Portmann BC, O’Grady JG, Naoumov NV, Alexander GJ, Williams R. Cytomegalovirus infection persists in the liver graft in the vanishing bile duct syndrome. Hepatology. 1992;16:285–92.

    Article  CAS  Google Scholar 

  41. Moseley RH, Wang W, Takeda H, Lown K, Shick L, Ananthanarayanan M, Suchy FJ. Effect of endotoxin. Post-liver transplant intrahepatic cholestasis: etiology, clinical presentation, therapy. Am J Phys. 1996;271(1 Pt 1):G137–46.

    CAS  Google Scholar 

  42. Bolder U, Ton-Nu HT, Schteingart CD, Frick E, Hofmann AF. Hepatocyte transport of bile acids and organic anions in endotoxemic rats: impaired uptake and secretion. Gastroenterology. 1997;112:214–25.

    Article  CAS  Google Scholar 

  43. Lamps LW, Pinson CW, Raiford DS, Shyr Y, Scott MA, Washington MK. The significance of microabscesses in liver transplant biopsies: a clinicopathological study. Hepatology. 1998;28:1532–7.

    Article  CAS  Google Scholar 

  44. Lefkowitch JH. Bile ductular cholestasis: an ominous histopathologic sign related to sepsis and “cholangitis lenta”. Hum Pathol. 1982;13:19–24.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Papa Giovanni XXIII Hospital, Bergamo, Italy

    Aurelio Sonzogni & Lisa Licini

  2. Paediatric Hepatology, Gastroenterology and Transplantation, Hospital Papa Giovanni XXIII, Bergamo, Italy

    Lorenzo D’Antiga

Authors
  1. Aurelio Sonzogni
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lisa Licini
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lorenzo D’Antiga
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Aurelio Sonzogni .

Editor information

Editors and Affiliations

  1. Paediatric Hepatology, Gastroenterology and Transplantation, Hospital Papa Giovanni XXIII Bergamo, Bergamo, Italy

    Lorenzo D'Antiga

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Sonzogni, A., Licini, L., D’Antiga, L. (2019). Pathology of Allograft Liver Dysfunction. In: D'Antiga, L. (eds) Pediatric Hepatology and Liver Transplantation. Springer, Cham. https://doi.org/10.1007/978-3-319-96400-3_32

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-96400-3_32

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-96399-0

  • Online ISBN: 978-3-319-96400-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation